Trials / Conditions / Erythropoietic Protoporphyria

Erythropoietic Protoporphyria

18 registered clinical trials studyying Erythropoietic Protoporphyria — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients NCT06388642	Clinuvel Europe Limited	Phase 1 / Phase 2
Enrolling By Invitation	HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-14 NCT05883748	Disc Medicine, Inc	Phase 2 / Phase 3
Unknown	Protection Against Visible Light by Dihydroxyacetone in Erythropoietic Protoporphyria NCT05780840	Bispebjerg Hospital	N/A
Completed	Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants Wi NCT05308472	Disc Medicine, Inc	Phase 2
Completed	Iron Therapy in Erythropoietic Protoporphyria NCT05572125	Bispebjerg Hospital	—
Completed	Effect of Oral Cimetidine in the Protoporphyrias NCT05020184	Amy K. Dickey, M.D.	Phase 2
Completed	Light Exposure Patterns and Symptoms Among Patients With Erythropoietic Protoporphyria NCT03682731	Bispebjerg Hospital	—
Completed	Oral Iron for Erythropoietic Protoporphyrias NCT02979249	Icahn School of Medicine at Mount Sinai	N/A
Completed	Erythropoietic Protoporphyrias: Studies of the Natural History, Genotype-Phenotype Correlations, and Psychosoc NCT01688895	Icahn School of Medicine at Mount Sinai	—
Completed	Phase III Confirmatory Study in Erythropoietic Protoporphyria NCT01605136	Clinuvel Pharmaceuticals Limited	Phase 3
Completed	A Safety Extension Study in Patients With Erythropoietic Protoporphyria (EPP) NCT04578496	Clinuvel Pharmaceuticals Limited	Phase 3
Completed	Sorbent Therapy of the Cutaneous Porphyrias NCT01422915	Brigham and Women's Hospital	Phase 2 / Phase 3
Completed	Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP) NCT01097044	Clinuvel Pharmaceuticals Limited	Phase 2
Completed	Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP) NCT00979745	Clinuvel Pharmaceuticals Limited	Phase 3
Completed	Multicentre Phase III Erythropoietic Protoporphyria Study NCT04053270	Clinuvel Pharmaceuticals Limited	Phase 3
Unknown	Does Exercise and Heat Increase the Lightsensibility in Patients With Erythropoietic Protoporphyria NCT00206869	Bispebjerg Hospital	N/A
Completed	Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria NCT00004831	FDA Office of Orphan Products Development	N/A
Completed	Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria NCT00004940	Brigham and Women's Hospital	Phase 3